Evaluation of microRNA‑9 and ‑192 Expression Levels as Biomarkers in Patients Suffering From Breast Cancer

Biomedical Reports - Greece
doi 10.3892/br.2019.1257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Evaluating the Expression Level of miR-9-5p and miR-192-5p in Gastrointestinal Cancer: Introducing Novel Screening Biomarkers for Patients

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2020English

Evaluation of miRNA-135a and miRNA-9 as Prognostic Markers in Breast Cancer Patients

Madridge Journal of Oncogenesis
2019English

Circulating microRNA-92a and microRNA-21 as Novel Minimally Invasive Biomarkers for Primary Breast Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2012English

NILCO Biomarkers in Breast Cancer From Chinese Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Expression Levels of microRNA-375 in Pancreatic Cancer

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2013English

Evaluation of Serum CEA and CA19-9 Levels as Prognostic Factors in Patients With Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2000English

Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2015English

MicroRNA‑192 Acts as a Tumor Suppressor in Colon Cancer and Simvastatin Activates miR‑192 to Inhibit Cancer Cell Growth

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

MicroRNA Expression Changes in Women With Breast Cancer Stratified by DNA Repair Capacity Levels

Journal of Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy